Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Bulletin Haiti.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on August 14, 2025
Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal
GlobeNewswire
·
August 14, 2025
- ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock split proposal - - Webcast to begin at 4:30 p.m. ET / 1:30 p.m. PT - SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a …
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
GlobeNewswire
·
August 14, 2025
POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for …
Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial Hazard ratios and improvements in median progression-free survival (“PFS”) are unprecedented …
Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
DARE to PLAY™ Sildenafil Cream on Track for Q4 2025 Launch via 503B Compounding Pathway; Positioned for Product Revenue Beginning in Q4 2025 Positive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Continued Enrollment Multiple Grant-Funded …
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
Patient dosing ongoing in CALiPSO-1 trial; on track to report clinical data for CNTY-101 in patients with B-cell-mediated autoimmune diseases by year-end 2025 CNTY-308, a CAR-iT cell therapy functionally comparable to primary T cells, now in IND-enabling …
Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress
GlobeNewswire
·
August 14, 2025
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of focusing on our base of routine users of optical …
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
GlobeNewswire
·
August 14, 2025
Newly-appointed President and CEO, Eric Risser, outlines strategic priorities for 2025 and 2026 Received $70 million upfront cash payment from Sagard Healthcare Partners under a royalty purchase agreement for ZYNYZ® Cash, cash equivalents and marketable …
Ligand Announces Closing of Convertible Senior Notes Offering
GlobeNewswire
·
August 14, 2025
JUPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today that it completed its previously announced offering (the “offering”) of 0.75% convertible senior notes due 2030 (the “notes”). …
Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal
GlobeNewswire
·
August 14, 2025
ALPHARETTA, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Heald, a pioneering digital health company specializing in Type 2 diabetes reversal through personalized lifestyle interventions, today announced a first of its kind money-back guarantee. Patients who …
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
GlobeNewswire
·
August 14, 2025
WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), today issued the following statement from Ryan Saadi, M.D., M.P.H., Founder and CEO. “Tevogen is an asset-rich enterprise, and we plan on …
Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care
GlobeNewswire
·
August 14, 2025
EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within the hematology community: whether the future belongs to …
Results of PBGH Transparency Initiative Provide Employers with New Insights on Commercial Health Care Pricing, Quality & Value: Register for Virtual Event 9/24 to Learn More
GlobeNewswire
·
August 14, 2025
Oakland, California, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Leveraging newly available transparency data to identify the real cost and value of commercial health care for self-insured employers, Purchaser Business Group on Health (PBGH), a nonprofit coalition …
Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight
GlobeNewswire
·
August 14, 2025
New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight The PH-ILD market is driven by increased disease …
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
GlobeNewswire
·
August 14, 2025
New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The vitiligo treatment landscape is evolving with a shift towards targeted …
Press release: Transparency Notification from Shareholders
GlobeNewswire
·
August 14, 2025
Transparency Notification from Shareholders Ghent, Belgium – 14 August 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure …
Sutter Health Receives $30 Million Kvamme Foundation Gift to Transform Cancer Care in Santa Cruz
GlobeNewswire
·
August 14, 2025
Santa Cruz, Aug. 14, 2025 (GLOBE NEWSWIRE) -- In a transformative act of generosity, the Jean and E. Floyd Kvamme Foundation has committed $30 million to Sutter Health to establish a new, state-of-the-art cancer center in Santa Cruz. This historic gift, …
HydroGraph Partners with Hawkeye Bio to Power Novel Graphene Biosensor Solution for LEAP™ Lung Cancer Test from Ease Healthcare
GlobeNewswire
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, today announced its role in a new lung cancer screening product underpinning a collaboration …
U.S. Oral Surgery Management Moves into 31st State
GlobeNewswire
·
August 14, 2025
IRVING, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has secured partnerships with four new practices, including its …
Industry 4.0 Market to Hit $1.6 Trillion Globally by 2030
GlobeNewswire
·
August 14, 2025
Boston, Aug. 14, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Industry 4.0 Technologies: Global Market Through 2030” is projected to increase from $655.2 billion in 2025 to reach $1.6 trillion by 2030, at a compound annual …
NIH Contract Expands DLH’s Position as a Digital Transformation and Cybersecurity Leader
GlobeNewswire
·
August 14, 2025
ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cyber security, science research and development, and systems engineering and integration, today …